Cancer and fertility preservation: international recommendations from an expert meetingMatteo Lambertini, Paola Anserini|BMC Medicine|2016Cited by 779
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice GuidelineCristiana Sessa, Shani Paluch–Shimon, Judith Balmañà et al.|Annals of Oncology|2022Cited by 271
Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysisLuca Arecco, Matteo Lambertini, Eva Blondeaux et al.|Human Reproduction|2022Cited by 105
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trialLucia Del Mastro, A Parisi, Francesca Poggio et al.|The Lancet Oncology|2022Cited by 50
Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysisAndrea Boutros, Francesco Spagnolo, Marco Bruzzone et al.|European Journal of Cancer|2021Cited by 42